SCHEDULE: Pluri Inc. Major Shareholder Ownership Update

Alexandre Weinstein and affiliated entities disclose a 34.98% beneficial ownership stake in Pluri Inc. following recent private placements.

Summary

• Reporting persons Chutzpah Holdings Limited (CHL), Chutzpah Holdings LP (CHLP), Plantae Bioscience Ltd., and Alexandre Weinstein have updated their collective beneficial ownership in Pluri Inc.
• The group holds an aggregate of 3,794,897 common shares, representing approximately 34.98% of the company's outstanding stock.
• Ownership includes direct holdings, shares acquired through private placements, and warrants subject to specific beneficial ownership limitations.
• Recent transactions include a March 2026 Securities Purchase Agreement involving 625,000 common shares and associated warrants.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal of long-term commitment from a major shareholder, though the high concentration of ownership and ongoing dilution warrant investor caution.

Positives

• Significant long-term commitment from a major shareholder group, indicating confidence in the company's strategic direction.
• Successful execution of multiple private placement offerings providing capital to the issuer.
• Clear disclosure of complex warrant structures and beneficial ownership limitations.

Negatives

• High concentration of ownership (nearly 35%) by a single individual and his affiliated entities may limit the influence of other shareholders.
• Dilutive impact of multiple private placements and warrant issuances on existing shareholders.

Risks

• Beneficial ownership limitations (35% cap) on warrants may restrict the ability of the reporting persons to exercise their full warrant holdings at certain times.
• Potential for future dilution if additional warrants are exercised or further capital raises occur.
• Reliance on the issuer's capitalization schedule for accurate ownership percentage calculations.

Future Outlook

The reporting persons intend to continue their investment in the Issuer and may acquire additional securities or dispose of holdings depending on market conditions and the Issuer's business performance.

Management Comments

• The reporting persons have entered into a joint filing agreement to coordinate their disclosures regarding their investment in the Issuer.

Industry Context

StockSavvy.ai notes that this filing reflects a trend of significant insider and major shareholder participation in the biotech sector to support ongoing R&D and operational funding requirements through private placements.

Comparison to Industry Standards

• The use of pre-funded warrants and beneficial ownership blockers is a standard mechanism in small-cap biotech financing to manage regulatory compliance and dilution.
• The 35% ownership threshold is a common contractual limit used by institutional investors to avoid triggering specific regulatory or change-of-control provisions.

Corporate Governance

Related Party Transactions

• The reporting persons are affiliates of the Issuer through significant equity ownership and board-related interests.
• The Kokomodo asset purchase involved the transfer of shares and convertible loans between the Issuer and entities controlled by Alexandre Weinstein.

Stakeholder Impact

• Existing shareholders face potential dilution from the exercise of warrants and issuance of new shares.
• The concentration of ownership may influence future corporate decision-making.

Next Steps

• Continued monitoring of warrant exercises by CHLP.
• Vesting of remaining RSUs for Alexandre Weinstein.
• Potential future amendments to Schedule 13D as ownership levels change.

Key Dates

Recommendation

The significant accumulation of shares by a major investor suggests confidence, but the ongoing dilution and complex warrant structures require a cautious 'hold' approach until the company demonstrates sustained operational growth.

Keywords

Pluri Inc., Schedule 13D, Alexandre Weinstein, Private Placement, Beneficial Ownership, Warrants, Equity Financing